Posted by Michael Wonder on 17 Feb 2026
New iron treatment funded for people who have experienced serious reactions
17 February 2026 - From 1 March 2026, PHARMAC will fund ferric derisomaltose (Monofer) in hospitals for people who have experienced serious reactions after other iron infusions.
PHARMAC consulted on a proposal to fund this medicine in January, following the discontinuation of iron as sucrose (Venofer) which is used by people who have experienced hypophosphataemia after other iron infusions.
